Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Exelixis Inc (NASDAQ: EXEL) closed the day trading at $46.61 up 0.91% from the previous closing price of $46.19. In other words, the price has increased by $0.91 from its previous closing price. On the day, 3.05 million shares were traded. EXEL stock price reached its highest trading level at $47.236 during the session, while it also had its lowest trading level at $45.955.
Ratios:
For a better understanding of EXEL, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.64 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.03. For the most recent quarter (mrq), Quick Ratio is recorded 3.68 and its Current Ratio is at 3.75. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.08.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 20 ’25 when Haley Patrick J. bought 10,648 shares for $41.78 per share.
JOHNSON DAVID EDWARD bought 27,532 shares of EXEL for $1,187,235 on Nov 25 ’25. The Director now owns 1,553,262 shares after completing the transaction at $43.12 per share. On Nov 20 ’25, another insider, Haley Patrick J., who serves as the EVP, Commercial of the company, sold 34,187 shares for $41.88 each. As a result, the insider received 1,431,757 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 12547529728 and an Enterprise Value of 11684635648. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.62, and their Forward P/E ratio for the next fiscal year is 14.45. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.43. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.46 while its Price-to-Book (P/B) ratio in mrq is 5.78. Its current Enterprise Value per Revenue stands at 5.106 whereas that against EBITDA is 13.747.
Stock Price History:
The Beta on a monthly basis for EXEL is 0.39, which has changed by 0.35733175 over the last 52 weeks, in comparison to a change of 0.13927746 over the same period for the S&P500. Over the past 52 weeks, EXEL has reached a high of $49.62, while it has fallen to a 52-week low of $31.90. The 50-Day Moving Average of the stock is 12.83%, while the 200-Day Moving Average is calculated to be 16.13%.
Shares Statistics:
Over the past 3-months, EXEL traded about 2.74M shares per day on average, while over the past 10 days, EXEL traded about 2937330 shares per day. A total of 268.10M shares are outstanding, with a floating share count of 259.61M. Insiders hold about 3.17% of the company’s shares, while institutions hold 95.93% stake in the company. Shares short for EXEL as of 1764288000 were 21360218 with a Short Ratio of 7.79, compared to 1761868800 on 19791732. Therefore, it implies a Short% of Shares Outstanding of 21360218 and a Short% of Float of 11.0.
Earnings Estimates
. The current market rating for Exelixis Inc (EXEL) reflects the collective analysis of 13.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.69, with high estimates of $0.82 and low estimates of $0.59.
Analysts are recommending an EPS of between $3.18 and $2.16 for the fiscal current year, implying an average EPS of $2.92. EPS for the following year is $3.28, with 13.0 analysts recommending between $3.91 and $2.55.
Revenue Estimates
17 analysts predict $609.25M in revenue for. The current quarter. It ranges from a high estimate of $631.03M to a low estimate of $530.4M. As of. The current estimate, Exelixis Inc’s year-ago sales were $566.75MFor the next quarter, 17 analysts are estimating revenue of $624.59M. There is a high estimate of $667.6M for the next quarter, whereas the lowest estimate is $593.67M.
A total of 19 analysts have provided revenue estimates for EXEL’s current fiscal year. The highest revenue estimate was $2.35B, while the lowest revenue estimate was $2.3B, resulting in an average revenue estimate of $2.33B. In the same quarter a year ago, actual revenue was $2.17BBased on 19 analysts’ estimates, the company’s revenue will be $2.61B in the next fiscal year. The high estimate is $2.96B and the low estimate is $2.44B.
